Results 181 to 190 of about 2,252 (197)

Kidney graft failure induced by BKPyV replication despite a strong reduction of the immunosuppressive therapy

Journal of Medical Virology, 2019
AbstractBKPyV replication is a risk factor for the development of polyomavirus‐associated nephropathy in kidney transplant recipients. Here, the case of a 42 years old Caucasian patient is described who developed a kidney allograft failure because of uncontrolled BKPyV replication 7 months after transplant despite a strong reduction of the ...
Alessandro Anselmo, Carla Prezioso, Federica Maria Di Lella   +2 more
exaly   +4 more sources

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Viral Immunology, 2017
To determine the association between BK polyomavirus (BKPyV) types 1 and 4 capsid antibody and natalizumab-associated progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS), serum samples were obtained from 10 natalizumab-associated PML cases and 130 control MS patients treated with natalizumab, and 82 control MS ...
Luca Prosperini, Nicola De Rossi, D Rivanera   +2 more
exaly   +3 more sources

Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients

Transplant Infectious Disease, 2020
AbstractBackgroundBK polymavirus (BKPyV), a member of the family Polyomaviridae, is associated with increased morbidity and mortality in allogeneic stem cell transplant recipients.MethodsIn our previous retrospective study of 2477 stem cell transplant patients, BKPyV replication independently predicted chronic kidney disease and poor survival.
Ala Abudayyeh, Heather Lin, Maen Abdelrahim, Gabriela Rondon, Borje S. Andersson, Charles S. Martinez, Valda D. Page, Jeffrey J. Tarrand, Dimitrios P. Kontoyiannis, David Marin, Betul Oran, Amanda Olson, Roy Jones, Uday Popat, Richard E. Champlin, Roy F. Chemaly, Elizabeth J. Shpall, Katayoun Rezvani   +17 more
openaire   +2 more sources

Detection of human JCPyV and BKPyV in diffuse large B-cell lymphoma of the GI tract

European Journal of Clinical Microbiology & Infectious Diseases, 2013
Previous studies have demonstrated that infection with human polyomavirus, such as JCPyV and BKPyV, might be associated with various human tumors. However, an association between human JCPyV and BKPyV infection and diffuse large B-cell lymphoma (DLBCL) has not been reported.
C E, Tseng, C M, Yeh, C Y, Fang, J, Shay, P L, Chen, M C, Lin, D, Chang, M, Wang   +7 more
openaire   +2 more sources

BK Polyomavirus (BKPyV) Serotype-Specific Antibody Responses in Blood Donors and Kidney Transplant Recipients with and without new-onset BKPyV-DNAemia: A Swiss Transplant Cohort Study.

Collaborators "Swiss Transplant Cohort Study": Annalisa Berzigotti, Guido Stirnimann , Vanessa Banz, Guido Beldi (UVCM Department of Visceral Surgery and Medicine).
Hillenbrand, Caroline A, Bani, Dorssa Akbari, Follonier, Océane, Kaur, Amandeep, Weissbach, Fabian H, Wernli, Marion, Wilhelm, Maud, Leuzinger, Karoline, Binet, Isabelle, Bochud, Pierre-Yves, Golshayan, Dela, Hirzel, Cédric, Manuel, Oriol, Mueller, Nicolas J, Schaub, Stefan, Schachtner, Thomas, Van Delden, Christian, Hirsch, Hans H   +17 more
openaire   +1 more source

#1560 Unveiling donor-originated BKPyV viremia in kidney transplant recipients

Nephrology Dialysis Transplantation
Abstract Background and Aims BK Polyomavirus (BKPyV) is of notable concern in kidney transplant recipients, as it can lead to BKPyV DNAemia and progress to BKPyV-associated nephropathy (BKPyVAN).
Wouter Moest, Lianne Messchendorp, Helma Dolmans, Maarten Christiaans, Arjan van Zuilen, M Kho, Jan-Stephan F Sanders, M C W Feltkamp, Aiko De Vries, Joris Rotmans   +9 more
openaire   +1 more source

BKPyV-specific T-cell Exhaustion in Kidney Transplant Recipients: Targeting Inhibitory Receptors Improves Their Functionality

Transplantation
Background. BK polyomavirus (BKPyV) nephropathy is a significant complication of kidney transplantation associated with high levels of BKPyV replication in plasma and poor graft survival. It is currently treated by reducing immunosuppression to restore the immune response.
Karen, Bargiel, Ivan, Scriabine, Florence, Herr, Marie-Ghislaine, de Goër de Herve, Houria, Hendel-Chavez, Yassine, Taoufik, Slim, Fourati, Manon, Dekeyser, Antoine, Durrbach   +8 more
openaire   +2 more sources

Impact of pre-graft serology on risk of BKPyV infection post-renal transplantation

Nephrology Dialysis Transplantation, 2022
François Helle, Gilles Duverlie, Sandrine Castelain   +2 more
exaly  

Diversité génétique et évolutivité du BKPyV in vivo chez les patients transplantés rénaux avec néphropathie à BKPyV

Médecine et Maladies Infectieuses Formation
J. Gras, M. Nere, J. Robert, M. Peraldi, L. Feghoul, J. Verine, A. Amara, J.M. Molina, C. Delaugerre, M. Salmona   +9 more
openaire   +1 more source

Infection by human polyomaviruses JCPyV and BKPyV in blood donors of Argentina

Vox Sanguinis, 2023
Maria C Frutos
exaly